149265 - The National Obesity Forum 2019
The National Obesity Tour 2019 is a succinct evening seminar that will be addressing the prevalent epidemic of obesity in Australia. This seminar will cover the neurohormonal aspects of weight regulation, provide an understanding of the scientific basis for the naltrexone bupropion combination for weight loss and provide practical advice on the quality use of medicines for the treatment of obesity- including patient selection criteria.
The event will be held in Perth, Adelaide, Sydney, Melbourne and Brisbane across different dates.
Obesity is highly relevant to both general practice and the community as excess weight, especially obesity, is a major risk factor for cardiovascular disease, Type 2 diabetes, some musculoskeletal conditions and some cancers (1). Obesity is the second highest contributor to burden of disease and further to this in 2014-15, 63.4% of Australian adults were overweight or obese which is an increase since 1995 (56.3%) and even more worrying is that around 27.4% of children aged 5 -17 years old were overweight or obese (2). A pilot study led by Dr Liz Sturgiss from the ANU Medical school found that GPs were well placed on the health frontline to help patients manage their weight, but they did not have the confidence to do so effectively (3). 1. AIHW (2017) - http://www.aihw.gov.au/overweight-and-obesity/ 2. ABS (2016) - http://www.abs.gov.au/ausstats/abs.nsf/mf/4364.0.55.001 3. ANU (2016) - http://www.anu.edu.au/news/all-news/gps-can-and-must-do-more-to-tackle-obesity-crisisLea rning outcomes